Abstract
Diabetes, both type 1 and type 2, is considered a chronic incurable disease. Complete cure would bring enormous benefits in terms of both the prevention of complications and reduction of the very high resulting social cost. Recent advances in the study of autoimmune mechanisms for type 1 and some non-medical therapeutic approaches for type 2 shed light on the pathophysiology and induce optimism concerning a possible cure in the not-too-distant future. This perspective highlights the main mechanisms involved in the pathophysiology of the two forms of diabetes, as the latest research has revealed, and the resulting possible therapeutic strategies that may be involved in obtaining a cure.
Keywords: Bariatric/metabolic surgery, gut-brain-liver/pancreas axis, neonatal transitory diabetes, oropharyngeal radiating therapy, T regulatory cells, type 1 diabetes pathophysiology, type 2 diabetes pathophysiology, vagal brainstem circuits.
Current Diabetes Reviews
Title:Can Diabetes Heal?- From Observations to Perspectives
Volume: 12 Issue: 3
Author(s): Claudio Blasi
Affiliation:
Keywords: Bariatric/metabolic surgery, gut-brain-liver/pancreas axis, neonatal transitory diabetes, oropharyngeal radiating therapy, T regulatory cells, type 1 diabetes pathophysiology, type 2 diabetes pathophysiology, vagal brainstem circuits.
Abstract: Diabetes, both type 1 and type 2, is considered a chronic incurable disease. Complete cure would bring enormous benefits in terms of both the prevention of complications and reduction of the very high resulting social cost. Recent advances in the study of autoimmune mechanisms for type 1 and some non-medical therapeutic approaches for type 2 shed light on the pathophysiology and induce optimism concerning a possible cure in the not-too-distant future. This perspective highlights the main mechanisms involved in the pathophysiology of the two forms of diabetes, as the latest research has revealed, and the resulting possible therapeutic strategies that may be involved in obtaining a cure.
Export Options
About this article
Cite this article as:
Blasi Claudio, Can Diabetes Heal?- From Observations to Perspectives, Current Diabetes Reviews 2016; 12 (3) . https://dx.doi.org/10.2174/1573399811666150702125702
DOI https://dx.doi.org/10.2174/1573399811666150702125702 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cigarette Smoking, Metabolic Activation and Carcinogenesis
Current Drug Metabolism Involvement of Mast Cells in Angiogenesis and Chronic Inflammation
Current Drug Targets - Inflammation & Allergy TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design Current Gene Therapy Strategies for Colorectal Cancer
Current Genomics Purinergic (P2) Receptor Control of Lower Genitourinary Tract Function and New Avenues for Drug Action: An Overview
Current Pharmaceutical Design Clinical Application of Percutaneous Puncture Biopsy Guided by Fused and 3D-reconstructed PET/CT Images
Current Medical Imaging Sp/KLF Family and Tumor Angiogenesis in Pancreatic Cancer
Current Pharmaceutical Design The Role of Apoptosis in Cancer Development and Treatment: Focusing on the Development and Treatment of Hematologic Malignancies
Current Pharmaceutical Design microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology A Perspective on Clinical Islet Transplantation: Past, Present and Developments for Future
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Small Molecules with EGFR-TK Inhibitor Activity
Current Drug Targets Long-Term Safety from the Raltegravir Clinical Development Program
Current HIV Research Regulation of EMT by Notch Signaling Pathway in Tumor Progression
Current Cancer Drug Targets Imaging Studies in Hypercalcemia
Current Medicinal Chemistry Lung Cancer: Are we up to the Challenge?
Current Genomics Current and Potential Anticancer Drugs Targeting Members of the UHRF1 Complex Including Epigenetic Modifiers
Recent Patents on Anti-Cancer Drug Discovery Recent Studies and Biological Aspects of Substantial Indole Derivatives with Anti-cancer Activity
Current Organic Chemistry Emerging Immunotargets and Immunotherapies in Prostate Cancer
Current Drug Targets Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence
Current Pharmaceutical Design Targeting Signalling Cross-Talk between Cancer Cells and Cancer-Associated Fibroblast through Monocarboxylate Transporters in Head and Neck Cancer
Anti-Cancer Agents in Medicinal Chemistry